Insight

Praveen Kumar Marimuthu: IMRT Not Better Than 3DCRT in RAPIDO

Praveen Kumar Marimuthu/X

May 13, 2025, 10:08

Praveen Kumar Marimuthu: IMRT Not Better Than 3DCRT in RAPIDO

Praveen Kumar Marimuthu, Assistant Professor – Medical Oncology at Christian Medical College and Hospital, shared on X about a recent paper by Max D. Tanaka et al. published in International Journal of Radiation Oncology, Biology, Physics:

“IMRT not better than 3DCRT in RAPIDO

IMRT did not result in less acute/ late toxicity, nor better Rx compliance vs. 3D-CRT after TNT/CRT in RAPIDO

Fatigue more frequent after IMRT

Literature review table shows no clear winner.”

Title: Acute and late radiation-related toxicity after treatment of locally advanced rectal cancer with IMRT compared to 3D-CRT in the RAPIDO trial

Authors: Max D. Tanaka, Bengt Glimelius, Geke A.P. Hospers, Elma Meershoek-Klein Kranenbarg, Corrie A.M. Marijnen, Hein Putter, Annet G.H. Roodvoets, Cornelis J.H. van de Velde, Boudewijn van Etten, Per J. Nilsson, Alice M. Couwenberg, Collaborative Investigators

Read Full Article.

Praveen Kumar Marimuthu

More posts featuring Praveen Kumar Marimuthu.

Alice M. Couwenberg Annet G.H. Roodvoets Bengt Glimelius Boudewijn van Etten cancer Collaborative Investigators Cornelis J. H. Van de Velde Corrie A.M. Marijnen Elma Meershoek-Klein Kranenbarg Geke A.P. Hospers GI oncology Hein Putter IMRT Max D. Tanaka OncoDaily Oncology Per J. Nilsson Praveen Kumar Marimuthu RAPIDO

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research

In Memory of Bob Marley: His Battle with Melanoma and the Importance of Early Detection

Who From Oncology is Featured in TIME100 Health 2025?

FDA Announces Aggressive Timeline to Scale 1st AI-Assisted Scientific Review Pilot

The Evolving Therapeutic Revolution in Adult Acute Lymphoblastic Leukemia